Amphista Therapeutics discloses first details of its TEAD Targeted Glue™ program and unveils new mechanism of action for TEAD degradation via FBXO22 First disclosure of a novel mechanism of action for ...
IT is nearly twenty years since Dr. Brunton, then a student in the University of Edinburgh, commenced, by his researches on the physiological action of digitalis, which were followed soon after by ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback